{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:16:31Z","timestamp":1790662591595,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1053\/j.ajkd.2021.03.020","type":"journal-article","created":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T11:45:41Z","timestamp":1621770341000},"page":"846-856.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label Extension"],"prefix":"10.1053","volume":"78","author":[{"given":"Pablo E.","family":"Pergola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson P.","family":"Kopyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1053\/j.ajkd.2021.03.020_bib1","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1185\/030079904X2763","article-title":"The prevalence of anemia in patients with chronic kidney disease","volume":"20","author":"McClellan","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1053\/j.ajkd.2021.03.020_bib2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinte.164.6.659","article-title":"Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization","volume":"164","author":"Keith","year":"2004","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1053\/j.ajkd.2021.03.020_bib3","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archinte.162.12.1401","article-title":"Association of kidney function with anemia: the third national health and nutrition examination survey (1988-1994)","volume":"162","author":"Astor","year":"2002","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1053\/j.ajkd.2021.03.020_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084943","article-title":"Prevalence of anemia in chronic kidney disease in the United States","volume":"9","author":"Stauffer","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1053\/j.ajkd.2021.03.020_bib5","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood.V60.6.1241.1241","article-title":"Erythropoiesis, erythropoietin, and iron","volume":"60","author":"Finch","year":"1982","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.ajkd.2021.03.020_bib6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s11255-020-02663-z","article-title":"Biomarkers of iron metabolism in chronic kidney disease","volume":"53","author":"Tomasz","year":"2021","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2021.03.020_bib7","first-page":"1","article-title":"Clinical practice guideline for the evaluation and management of chronic kidney disease (CKD)","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"10","key":"10.1053\/j.ajkd.2021.03.020_bib8","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/gut.2010.228874","article-title":"Guidelines for the management of iron deficiency anaemia","volume":"60","author":"Goddard","year":"2011","journal-title":"Gut"},{"issue":"2","key":"10.1053\/j.ajkd.2021.03.020_bib9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1681\/ASN.2006080856","article-title":"Clinical aspects of iron use in the anemia of kidney disease","volume":"18","author":"H\u00f6rl","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2021.03.020_bib10","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1111\/hdi.12562","article-title":"Clinical practice guidelines on iron therapy: a critical evaluation","volume":"21","author":"Del Vecchio","year":"2017","journal-title":"Hemodial Int"},{"issue":"3","key":"10.1053\/j.ajkd.2021.03.020_bib11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10620-009-1108-6","article-title":"Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective","volume":"55","author":"Zhu","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1053\/j.ajkd.2021.03.020_bib12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1046\/j.1365-2036.1998.00380.x","article-title":"Ferric trimaltol corrects iron deficiency anaemia in patients intolerant of iron","volume":"12","author":"Harvey","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.ajkd.2021.03.020_bib13","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.14309\/00000434-200910003-00573","article-title":"Hemorrhagic gastric ulcer secondary to ferrous sulfate: 573","volume":"104","author":"Kittaneh","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1053\/j.ajkd.2021.03.020_bib14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/00365520310000771","article-title":"Ferrous fumarate deteriorated plasma antioxidant status in patients with crohn disease","volume":"38","author":"Erichsen","year":"2003","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1053\/j.ajkd.2021.03.020_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/00313029600169763","article-title":"Iron tablets cause histopathologically distinctive lesions in mucosal biopsies of the stomach and esophagus","volume":"28","author":"Eckstein","year":"1996","journal-title":"Pathology"},{"issue":"9","key":"10.1053\/j.ajkd.2021.03.020_bib16","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.drudis.2015.07.005","article-title":"Addressing unmet needs in inflammatory bowel disease","volume":"20","author":"Bokemeyer","year":"2015","journal-title":"Drug Discov Today"},{"issue":"2","key":"10.1053\/j.ajkd.2021.03.020_bib17","article-title":"Oxidative stress gated by fenton and haber weiss reactions and its association with Alzheimer\u2019s disease","volume":"2","author":"Das","year":"2015","journal-title":"Arch Neurosci"},{"issue":"11","key":"10.1053\/j.ajkd.2021.03.020_bib18","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/ndt\/gfu201","article-title":"Find-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia","volume":"29","author":"Macdougall","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2021.03.020_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.ackd.2019.05.002","article-title":"Novel oral iron therapies for iron deficiency anemia in chronic kidney disease","volume":"26","author":"Pergola","year":"2019","journal-title":"Adv Chron Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2021.03.020_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2710.1991.tb00292.x","article-title":"Absorption of low and therapeutic doses of ferric maltol, a novel ferric iron compound, in iron deficient subjects using a single dose iron absorption test","volume":"16","author":"Kelsey","year":"1991","journal-title":"J\u00a0Clin Pharm Ther"},{"issue":"3","key":"10.1053\/j.ajkd.2021.03.020_bib21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1476-5381.1991.tb12240.x","article-title":"Dissociation of a ferric maltol complex and its subsequent metabolism during absorption across the small intestine of the rat","volume":"102","author":"Barrand","year":"1991","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1053\/j.ajkd.2021.03.020_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1079\/BJN19940127","article-title":"Absorption of iron from ferric hydroxypyranone complexes","volume":"71","author":"Maxton","year":"1994","journal-title":"Br J Nutr"},{"issue":"18","key":"10.1053\/j.ajkd.2021.03.020_bib23","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1517\/14656566.2015.1096929","article-title":"Ferric maltol (st10): a novel oral iron supplement for the treatment of iron deficiency anemia in inflammatory bowel disease","volume":"16","author":"Stallmach","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"10.1053\/j.ajkd.2021.03.020_bib24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/MIB.0000000000000314","article-title":"Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program","volume":"21","author":"Gasche","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2021.03.020_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/apt.13665","article-title":"Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a phase 3 study","volume":"44","author":"Schmidt","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2021.03.020_bib26","first-page":"S16","article-title":"Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults","volume":"47","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2021.03.020_bib29","article-title":"Parenteral versus oral iron therapy for adults and children with chronic kidney disease","volume":"2","author":"O\u2019Lone","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1053\/j.ajkd.2021.03.020_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117383","article-title":"Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis","volume":"10","author":"Tolkien","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1053\/j.ajkd.2021.03.020_bib31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1476-5381.1991.tb12187.x","article-title":"Evidence for regulatory control of iron uptake from ferric maltol across the small intestine of the rat","volume":"102","author":"Barrand","year":"1991","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1053\/j.ajkd.2021.03.020_bib32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2257.1989.tb00222.x","article-title":"Absorption of ferric maltol, a novel ferric iron compound, in iron-deficient subjects","volume":"11","author":"Kelsey","year":"1989","journal-title":"Clin Lab Haematol"},{"issue":"3","key":"10.1053\/j.ajkd.2021.03.020_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.2042-7158.1987.tb06249.x","article-title":"Effects of the pyrones, maltol and ethyl maltol, on iron absorption from the rat small intestine","volume":"39","author":"Barrand","year":"1987","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"10","key":"10.1053\/j.ajkd.2021.03.020_bib34","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638621006247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638621006247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:38:11Z","timestamp":1759462691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638621006247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0272638621006247"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2021.03.020","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label Extension","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2021.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}